Trials / Recruiting
RecruitingNCT06949774
INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)
INcentives and ReMINDers to Improve Long-term Medication Adherence
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 550 (estimated)
- Sponsor
- RAND · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Low medication adherence when initiating antiretroviral treatment (ART) is a key barrier to HIV virologic suppression, resulting in avoidable cases of drug resistance, death, and viral transmission. Routinized pill-taking can lead to successful long-term ART adherence, and short-term behavioral economics-based supports are a novel way to overcome the limited success of existing routinization interventions. This study proposes to test this combined approach for promoting long-term ART adherence using a Stage III Sequential, Multiple Assignment, Randomized Trial (SMART) design in one of the largest HIV clinics in Uganda to identify the most cost-effective adaptive intervention that if found effective is generalizable to other settings and other chronic diseases.
Detailed description
Building on a previous R34 study, the investigators will adapt and deliver the INMIND approach to 550 ART initiators at Mildmay. Participants will initially be randomized to receive either usual care (Control, n=275) or daily text messages (Messages, n=275) to support adherence routines. At months 1 and 2, participants may revise their adherence plans. Those showing \<80% adherence in month 3 will be re-randomized to receive either monthly or monthly escalated prize incentives for the next three months. Adherence will be monitored for an additional 12 months (total follow-up: 18 months) to assess long-term routine maintenance and recovery after interruptions. The SMART design will help identify the most cost-effective intervention sequencing. A cost-effectiveness analysis and stakeholder dissemination will support future scale-up. The investigators hypothesize that Messages will be more effective than Control as a first-stage treatment; that monthly escalated prizes will be more effective than monthly prizes as a second-stage treatment; and that the mechanisms of lack of Salience and Present Bias will mediate the effect of INMIND on our primary and secondary outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Daily Text Messages | Participants will receive daily text message reminders to use their routine behavior to trigger medication adherence. |
| BEHAVIORAL | Incentivization based on timely ART adherence | Participants will be eligible to (draw a prize in monthly prize group) or get a monthly prize (monthly escalated group) if they take their medication within +/-one hour of the stated existing routine to which pill-taking is anchored on at least 80% of days for 3-months. |
Timeline
- Start date
- 2025-04-02
- Primary completion
- 2028-12-31
- Completion
- 2029-10-31
- First posted
- 2025-04-29
- Last updated
- 2025-09-11
Locations
1 site across 1 country: Uganda
Source: ClinicalTrials.gov record NCT06949774. Inclusion in this directory is not an endorsement.